Dr Reddys Laboratories Ltd Share Price Today - Live Blog for April 21, 2026

Dr Reddys Laboratories Ltd stock price decreased by -0.98%, with the current market value at 1220.50 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd's share price has fallen by -0.99%, presenting both challenges and opportunities for investors. As of now, it's trading at 1220.40, and market participants are assessing the implications. The stock has a PE ratio of 18.6200, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd shares experienced a -0.99% reduction, with the current market price at 1220.40. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd's share price has fallen by -0.97%, presenting both challenges and opportunities for investors. As of now, it's trading at 1220.60, and market participants are assessing the implications. The stock has a PE ratio of 18.6200, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.97% drop, and it's now trading at 1220.60 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd experienced a -1.02% dip in its share price and is currently trading at 1220.00. The stock has a PE ratio of 18.6200, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

With a -1.02% decrease, Dr Reddys Laboratories Ltd's share price is currently at 1220.00. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.6200, while the industry PE is 32.3840.

The share price of Dr Reddys Laboratories Ltd experienced a -0.65% slump and is currently trading at 1224.60. While the stock maintains a PE ratio of 18.6200, the industry PE is 32.3840, raising questions about valuation.

Dr Reddys Laboratories Ltd stock price decreased by -0.65%, with the current market value at 1224.60 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd observed a -0.65% decrease in its share price, a situation that merits attention. As of now, it's actively trading at 1224.60. The stock has a PE ratio of 18.6200, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd suffered a -0.65% decline, and it currently trades at 1224.60 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.